CLIFF FERREIRA: Open Payments
NPI 1104352319 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 23 payments from 8 companies in 2025. Trend: 2023 $345 · 2024 $184 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 5 | $102 |
| Sumitomo Pharma America, Inc. | 5 | $98 |
| UROGEN PHARMA, INC. | 3 | $59 |
| Verity Pharmaceuticals Inc. | 3 | $59 |
| TOLMAR, INC. | 3 | $56 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $29 |
| pharmaand GmbH | 1 | $22 |
| ABBVIE INC. | 1 | $15 |
Products named: XYOSTED, GEMTESA, JELMYTO, Trelstar, JATENZO, Personal Catheter Intermittent Catheter, Tlando, ELIGARD.
Industry payments across MI — which companies pay providers there.
